Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57B16 and ICR mice-Reference-Cited by-同舟云学术

Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57B16 and ICR mice

Published:1992-05 Issue:1 Volume:114 Page:1-8
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Kanekal Sarathchandra,Fraiser Lucy,Kehrer James P.

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference26 articles.

1. Metabolism of cyclophosphamide;Brock;Cancer,1967

2. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: Factors affecting the relative rates of conjugate formation;Buckpitt;J. Pharmacol. Exp. Ther.,1984

3. Observations on the metabolism of cyclophosphamide;Connors;Biochem. Pharmacol.,1972

4. Drug-induced pulmonary disease;Cooper;Am. Rev. Respir. Dis.,1986

5. Cyclophosphamide cystitis—identification of acrolein as the causative agent;Cox;Biochem. Pharmacol.,1979

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-Induced Changes in the Lung Microenvironment: The Role of MMP-2 in Facilitating Intravascular Arrest of Breast Cancer Cells;International Journal of Molecular Sciences;2021-09-24

2. Amelioration of cyclophosphamide toxicity via modulation of metabolizing enzymes by avocado (Persea americana) extract;Journal of Pharmacy and Pharmacology;2021-06-26

3. Characterization and Validation of a Chronic Model of Cyclophosphamide-Induced Interstitial Cystitis/Bladder Pain Syndrome in Rats;Frontiers in Pharmacology;2020-08-28

4. Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury;Acta Pharmacologica Sinica;2011-04-18

5. Cystitis increases colorectal afferent sensitivity in the mouse;American Journal of Physiology-Gastrointestinal and Liver Physiology;2009-12